Skip to main content
    S

    SkinHealth Systems Inc. (SKIN)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ

    $15.05
    -1.26 (-7.73%)

    Market Cap: $106.26M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    SkinHealth Systems Inc. (SKIN) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect SkinHealth Systems (SKIN) to earn $1.90 per share in the fiscal year ending Dec 31, 2026, on revenue of $285.17M. Of 9 analysts, 1 rates the stock Buy or Strong Buy, 6 Hold and 2 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 3.33, inside the Hold band from 2.5 up to 3.5. Sell and Strong Sell make up 22% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy111.1%
    Hold666.7%
    Sell00.0%
    Strong Sell222.2%
    Consensus
    Hold
    Total analysts
    9

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 76.8% and revenue estimates rise 1.3%.

    Fiscal year ending Dec 31, 2026
    $1.90
    EPS consensus, revenue $285.17M
    Fiscal year ending Dec 31, 2027
    $3.36
    EPS consensus, revenue $288.89M
    Next report
    Mar 10, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.90$1.90 to $1.901$285.17M$283.37M to $286.90M9
    Dec 31, 2027$3.36$3.36 to $3.361$288.89M$282.90M to $295.49M9

    Quarterly Estimates

    The EPS consensus falls from -$0.47 for the quarter ending Dec 31, 2026 to -$0.75 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.47-$0.96 to -$0.1411$81.25M$76.34M to $87.36M11
    Mar 31, 2027-$0.75-$0.99 to -$0.524$65.10M$62.90M to $68.10M5

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 2 upward and 3 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202712

    EPS Trend

    Over the last 60 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 26.9% from $2.60.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$1.90$2.56$2.60$2.60N/AN/A
    Fiscal year ending Dec 31, 2027$3.36$3.82$3.80$3.80$3.00+12.0%
    Quarter ending Mar 31, 2027-$0.75-$0.44-$0.44-$0.44-$0.44N/A

    Frequently Asked Questions About SKIN

    What is the SKIN stock forecast?

    Consensus analyst estimates put SkinHealth Systems's EPS at $1.90 for the fiscal year ending Dec 31, 2026, on revenue of $285.17M. The consensus rating from 9 analysts is Hold.

    How do analysts rate SKIN stock?

    Of 9 analysts covering SkinHealth Systems, 0 rate it Strong Buy, 1 Buy, 6 Hold, 0 Sell and 2 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from SKIN next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.90, with estimates from $1.90 to $1.90 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $3.36, with estimates from $3.36 to $3.36 from 1 analyst.

    What revenue do analysts expect from SkinHealth Systems next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $285.17M, with estimates from $283.37M to $286.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $288.89M, with estimates from $282.90M to $295.49M.

    How many analysts cover SKIN?

    9 analysts rate SkinHealth Systems stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.